4//SEC Filing
AMEDISYS INC 4
Accession 0000899243-17-005328
CIK 0000896262operating
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 9:00 PM ET
Size
7.8 KB
Accession
0000899243-17-005328
Insider Transaction Report
Form 4
AMEDISYS INCAMED
Sender Susan
Chief Clinical Officer
Transactions
- Exercise/Conversion
Common Stock
2017-02-22+5,016→ 11,704 total - Exercise/Conversion
Restricted Stock Units
2017-02-22−5,016→ 15,047 total→ Common Stock (5,016 underlying)
Footnotes (1)
- [F1]The Restricted Stock Units ("RSUs") are subject to performance-based vesting and will vest (i) on the certification by the Compensation Committee of the Issuer's Board of Directors of the achievement of identified performance goals for fiscal years 2016 through 2019, respectively, and (ii) additional time-based vesting conditions (2016 Tranche: one-third on each of September 27, 2017, 2018 and 2019; 2017 Tranche: one-third on each of September 27, 2018, 2019 and 2020; 2018 Tranche: one-third on each of September 27, 2019, 2020 and 2021; 2019 Tranche: one-third on each of September 27, 2020, 2021 and 2022), assuming the Reporting Person remains continuously employed by the Issuer on each such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs. The performance criteria for fiscal year 2016 were met.
Documents
Issuer
AMEDISYS INC
CIK 0000896262
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000896262
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 9:00 PM ET
- Size
- 7.8 KB